Dr. Juan Sanchez | VP, Corporate Communications and IR |
Dr. Sharon Mates | Chairman and CEO |
Dr. Andrew Satlin | EVP and Chief Medical Officer |
Mark Neumann | EVP and Chief Commercial Officer |
Larry Hineline | EVP and CFO |
Charles Duncan | Cantor Fitzgerald |
Jessica Fye | JP Morgan |
Bo Chen | Evercore ISI |
Sumant Kulkarni | Canaccord |
Marc Goodman | SVB Leerink |
Brian Abrahams | RBC Capital Markets |
Andrew Tsai | Jefferies |
Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies' First Quarter Ended March 31, 2020 Financial Results Conference Call.
As a reminder, today's call is being recorded. [Operator Instructions]
I'd now like to turn the conference over to your host, Dr. Juan Sanchez, Vice President, Corporate Communications and Investor Relations.